臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"liu c h"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 681-730 / 1570 (共32頁)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2021-05-07T02:05:59Z	Peroxiredoxin 1 induces inflammatory cytokine response and predicts outcome of cardiogenic shock patients necessitating extracorporeal membrane oxygenation: An observational cohort study and translational approach	Liu C.-H.; Kuo S.-W.; Hsu L.-M.; Huang S.-C.; CHIH-HSIEN WANG; Tsai P.-R.; Chen Y.-S.; Jou T.-S.; Ko W.-J.
臺大學術典藏	2021-05-07T02:05:55Z	Early measurement of IL-10 predicts the outcomes of patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation /631/250/127 /692/53/2422 /13 /13/21 /13/31 /45/23 article	Liu C.-H.; Kuo S.-W.; Ko W.-J.; Tsai P.-R.; Wu S.-W.; Lai C.-H.; CHIH-HSIEN WANG; Chen Y.-S.; Chen P.-L.; Liu T.-T.; Huang S.-C.; Jou T.-S.
臺大學術典藏	2021-05-06T02:22:19Z	Relationship of international normalized ratio to bleeding and thromboembolism rates in Taiwanese patients receiving vitamin K antagonist after mechanical valve replacement	HSI-YU YU; Liu C.-H.; Chen Y.-S.; Wang S.-S.; Chu S.-H.; Lin F.-Y.
臺大學術典藏	2021-05-06T02:22:11Z	Is old age a contraindication for surgical treatment in acute aortic dissection? A demographic study of national database registry in Taiwan	Wu I.-H.; HSI-YU YU; Liu C.-H.; Chen Y.-S.; Wang S.-S.; Lin F.-Y.
臺大學術典藏	2021-05-06T01:25:13Z	Evolution of estimated glomerular filtration rate in human immunodeficiency virus and hepatitis C virus-coinfected patients receiving sofosbuvir-based direct-acting antivirals and antiretroviral therapy	Liu C.-H.; Sun H.-Y.; Hsieh S.-M.; Liu W.-C.; Sheng W.-H.; Liu C.-J.; Su T.-H.; Tseng T.-C.; Chen P.-J.; CHIEN-CHING HUNG; Kao J.-H.
臺大學術典藏	2021-05-06T01:25:13Z	Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan	Liu C.-H.; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; Liu C.-J.; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; Fang Y.-J.; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; CHIEN-CHING HUNG; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T.?Y.; Kao J.-H.
臺大學術典藏	2021-05-03T09:17:11Z	Genome-wide epigenetic landscape of lung adenocarcinoma links HOXB9 DNA methylation to intrinsic EGFR-TKI resistance and heterogeneous responses	Su S.-F.; Liu C.-H.; Cheng C.-L.; CHAO-CHI HO; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Chen H.-W.; Chang G.-C.; Yu S.-L.; Li K.-C.
臺大學術典藏	2021-05-03T02:20:56Z	β-1,4-Galactosyltransferase III suppresses β1 integrin-mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer	Chen C.-H.; Wang S.-H.; Liu C.-H.; Wu Y.-L.; Wang W.-J.; Huang J.; Hung J.-S.; Lai I.-R.; JIN-TUNG LIANG; Huang M.-C.
臺大學術典藏	2021-05-02T02:52:07Z	Losartan reduces ensuing chronic kidney disease and mortality after acute kidney injury	Cheng S.-Y.; Chou Y.-H.; Liao F.-L.; Lin C.-C.; Chang F.-C.; Liu C.-H.; Huang T.-M.; CHUN-FU LAI; Lin Y.-F.; Wu V.-C.; Chu T.-S.; Wu M.-S.; Lin S.-L.
臺大學術典藏	2021-04-29T05:09:02Z	R331W missense mutation of oncogene YAP1 is a germline risk allele for lung adenocarcinoma with medical actionability	Chen H.-Y.; Yu S.-L.; Ho B.-C.; Su K.-Y.; Hsu Y.-C.; Chang C.-S.; Li Y.-C.; Yang S.-Y.; Hsu P.-Y.; Ho H.; Chang Y.-H.; Chen C.-Y.; Yang H.-I.; Hsu C.-P.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Hsia J.-Y.; Chuang C.-Y.; Yuan S.; Lee M.-H.; Liu C.-H.; Wu G.-I.; Hsiung C.A.; Chen Y.-M.; Wang C.-L.; Huang M.-S.; Yu C.-J.; KUAN-YU CHEN; Tsai Y.-H.; Su W.-C.; Chen H.-W.; Chen J.J.W.; Chen C.-J.; Chang G.-C.; Yang P.-C.; Li K.-C.
臺大學術典藏	2021-04-22T06:56:48Z	Biliary hamartomas with delayed 99mTc-diisopropyl iminodiacetic acid clearance	Liu C.-H.; Yen R.-F.; Liu K.-L.; Jeng Y.-M.; Pan M.-H.; PEI-MING YANG
臺大學術典藏	2021-04-22T06:56:47Z	Gastroduodenal corrosive injury after oral zinc oxide	Liu C.-H.; Lee C.-T.; Tsai F.-C.; Hsu S.-J.; PEI-MING YANG
臺大學術典藏	2021-04-22T06:56:47Z	Splenic vein thrombosis and Klebsiella pneumoniae septicemia after endoscopic gastric variceal obturation therapy with N-butyl-2-cyanoacrylate	Liu C.-H.; Tsai F.-C.; Liang P.-C.; Lee C.-Z.; PEI-MING YANG
臺大學術典藏	2021-04-22T06:56:46Z	Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases	Liu C.-H.; Lin J.-W.; Tsai F.-C.; PEI-MING YANG; Lai M.-Y.; Chen J.-H.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-04-22T06:56:46Z	Gastroduodenal corrosive injury after oral zinc oxide [4]	Liu C.-H.; Lee C.-T.; Tsai F.-C.; Hsu S.-J.; PEI-MING YANG
臺大學術典藏	2021-04-22T06:56:45Z	Successful colonoscopic drainage of appendiceal pus in acute appendicitis	Liu C.-H.; Tsai F.-C.; Hsu S.-J.; PEI-MING YANG
臺大學術典藏	2021-04-22T06:56:44Z	Enterolith ileus in a patient with jejunal diverticulosis: Sonographic findings	Liu C.-H.; Huang K.-W.; Mo Y.-H.; PEI-MING YANG
臺大學術典藏	2021-04-22T06:56:43Z	Esophageal varices: Noninvasive diagnosis with duplex doppler US in patients with compensated cirrhosis	Liu C.-H.; Hsu S.-J.; Liang C.-C.; Tsai F.-C.; Lin J.-W.; Liu C.-J.; PEI-MING YANG; Lai M.-Y.; Chen P.-J.; Chen J.-H.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-04-16T07:31:05Z	Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load	Chiu H.-M.;Jen G.H.-H.;Wang Y.-W.;Fann J.C.-Y.;Hsu C.-Y.;Jeng Y.-C.;Yen A.M.-F.;Chiu S.Y.-H.;Chen S.L.-S.;Hsu W.-F.;Lee Y.-C.;Wu M.-S.;Wu C.-Y.;Jou Y.-Y.;Hsiu-Hsi Chen; Tseng T.-C.; Liu C.-J.; Yang W.-T.; Hsu C.-Y.; Hong C.-M.; Su T.-H.; Tsai C.-H.; Chen C.-L.; Yang H.-C.; Liu C.-H.; HSIU-HSI CHEN; Chen P.-J.; Kao J.-H.
臺大學術典藏	2021-04-16T07:31:05Z	Risk stratification for gastric cancer after Helicobacter pylori eradication: A population-based study on Matsu Islands	Tseng T.-C.;Liu C.-J.;Yang W.-T.;Hsu C.-Y.;Hong C.-M.;Su T.-H.;Tsai C.-H.;Chen C.-L.;Yang H.-C.;Liu C.-H.;Hsiu-Hsi Chen;Chen P.-J.;Kao J.-H.; Chiang T.-H.; Maeda M.; Yamada H.; Chan C.-C.; Chen S.L.-S.; Chiu S.Y.-H.; Chen Y.-N.; Chou Y.-H.; Shieh C.-F.; Liu C.-Y.; Chiu H.-M.; Chiang H.; Shun C.-T.; Lin M.-W.; Wu M.-S.; Lin J.-T.; HSIU-HSI CHEN; Ushijima T.; Graham D.Y.; Lee Y.-C.
臺大學術典藏	2021-03-15T07:59:52Z	Seroepidemiology of Human T-Cell Lymphotropic Virus Type I Infection in Taiwan	Wang C.-H.;Chen C.-J.;Chung-Yi Hu;You S.-L.;Chu C.-T.;Chou M.-J.;Essex M.;Blattner W.A.;Liu C.-H.;Yang C.-S.; Wang C.-H.; Chen C.-J.; CHUNG-YI HU; You S.-L.; Chu C.-T.; Chou M.-J.; Essex M.; Blattner W.A.; Liu C.-H.; Yang C.-S.
臺大學術典藏	2021-03-15T07:59:52Z	Infection of human T-cell leukemia virus type I and development of human T-cell leukemia/lymphoma in patients with hematologic neoplasms: A possible linkage to blood transfusion	Chen Y.-C.;Wang C.-H.;Su I.-J.;Chung-Yi Hu;Chou M.-J.;Lee T.-H.;Lin D.-T.;Chung T.-Y.;Liu C.-H.;Yang C.-S.; Chen Y.-C.; Wang C.-H.; Su I.-J.; CHUNG-YI HU; Chou M.-J.; Lee T.-H.; Lin D.-T.; Chung T.-Y.; Liu C.-H.; Yang C.-S.
臺大學術典藏	2021-03-12T02:28:42Z	Risk factors of hepatitis during Anti-tuberculous treatment and implications of hepatitis virus load	Wang J.-Y.;Liu C.-H.;Hu F.-C.;Chang H.-C.;Liu J.-L.;Chen J.-M.;Yu C.-J.;Li-Na Lee;Kao J.-H.;Yang P.-C.; Wang J.-Y.; Liu C.-H.; Hu F.-C.; Chang H.-C.; Liu J.-L.; Chen J.-M.; Yu C.-J.; LI-NA LEE; Kao J.-H.; Yang P.-C.
臺大學術典藏	2021-03-09T06:46:21Z	Hodgkin's disease and non?hodgkin's lymphoma containing reed?sternberg?like giant cells in Taiwan: A clinicopathologic analysis of 50 cases	RUEY-LONG HONG; Su I.?J.; Chen Y.?C.; Hsieh H.?C.; Wang C.?H.; Liu C.?H.; Shen M.?C.
臺大學術典藏	2021-03-09T01:47:47Z	Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B	TUNG-HUNG SU; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:46Z	HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses	Yu M.-L.; Lee C.-M.; Chuang W.-L.; Lu S.-N.; Dai C.-Y.; Huang J.-F.; Lin Z.-Y.; Hu T.-I.; Chen C.-H.; Hung C.-.; Wang J.-H.; Chen C.-L.; Kao J.-H.; Lai M.-Y.; Liu C.-H.; TUNG-HUNG SU; Wu S.-S.; Liao L.-Y.; Kuo H.-T.; Chao Y.-C.; Tung S.-Y.; Yang S.-S.; Chen P.-J.; Liu C.-J.; Chen D.-S.
臺大學術典藏	2021-03-09T01:47:46Z	Interleukin 28B genetic polymorphisms play a minor role in identifying optimal treatment duration in HCV genotype 1 slow responders to pegylated interferon plus ribavirin	Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:46Z	Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy	Liu C.-H.; Liang C.-C.; Liu C.-J.; Tseng T.-C.; Lin C.-L.; Yang S.-S.; TUNG-HUNG SU; Hsu S.-J.; Lin J.-W.; Chen J.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:45Z	Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load	Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:45Z	High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load	Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:44Z	Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion	Yang H.-C.; Chen C.-L.; Shen Y.-C.; Peng C.-Y.; Liu C.-J.; Tseng T.-C.; TUNG-HUNG SU; Chuang W.-L.; Yu M.-L.; Dai C.-Y.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:44Z	Young chronic hepatitis b patients with nucleos(t)ide analogue-induced hepatitis b e antigen seroconversion have a higher risk of HBV reactivation	Tseng T.-C.; Liu C.-J.; TUNG-HUNG SU; Yang H.-C.; Wang C.-C.; Chen C.-L.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:43Z	Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads	Tseng T.-C.; Liu C.-J.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Chen C.-L.; Hsu C.-A.; Fang-Tzu Kuo S.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:43Z	Longitudinal Change of HBsAg in HBeAg-negative Patients with Genotype B or C Infection	TUNG-HUNG SU; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen C.-L.; Chen P.-J.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-03-09T01:47:42Z	Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers	Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Yang W.-T.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:42Z	Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C	TUNG-HUNG SU; Liu C.-H.; Liu C.-J.; Chen C.-L.; Ting T.-T.; Tseng T.-C.; Chen P.-J.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-03-09T01:47:41Z	Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters	Tseng T.-C.; Liu C.-J.; Yang W.-T.; Chen C.-L.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:41Z	Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: A randomized trial	Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Chen S.-I.; Lin J.-W.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:41Z	Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy	TUNG-HUNG SU; Liu C.-J.; Yang H.-C.; Jeng Y.-M.; Cheng H.-R.; Liu C.-H.; Tseng T.-C.; Ling T.-Y.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:40Z	Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin	Chen M.-Y.; Liu C.-H.; Chen T.-C.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Kao J.-H.; Liu C.-J.
臺大學術典藏	2021-03-09T01:47:40Z	Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously	Cheng H.-R.; Kao J.-H.; Wu H.-L.; Chen T.-C.; Tseng T.-C.; Liu C.-H.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏	2021-03-09T01:47:40Z	Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: Clinical and mechanistic implications	Wu H.-L.; Kao J.-H.; Chen T.-C.; Wu W.-H.; Liu C.-H.; TUNG-HUNG SU; Yang H.-C.; Chen D.-S.; Chen P.-J.; Liu C.-J.
臺大學術典藏	2021-03-09T01:47:39Z	Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection	Cheng H.-R.; Kao J.-H.; Wu H.-L.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; TUNG-HUNG SU; Chen P.-J.; Chen D.-S.; Liu C.-J.
臺大學術典藏	2021-03-09T01:47:38Z	Serum biomarkers predictive of significant fibrosis and cirrhosis in chronic hepatitis B	Lin C.-L.; Liu C.-H.; Wang C.-C.; Liang C.-C.; TUNG-HUNG SU; Liu C.-J.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:37Z	Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition	TUNG-HUNG SU; Shiau C.-W.; Jao P.; Liu C.-H.; Liu C.-J.; Tai W.-T.; Jeng Y.-M.; Yang H.-C.; Tseng T.-C.; Huang H.-P.; Cheng H.-R.; Chen P.-J.; Chen K.-F.; Kao J.-H.; Chen D.-S.
臺大學術典藏	2021-03-09T01:47:37Z	Comparison of abbott realtime HCV genotype II with versant line probe assay 2.0 for hepatitis C virus genotyping	Liu C.-H.; Liang C.-C.; Liu C.-J.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:37Z	Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection	Tseng T.-C.; Liu C.-J.; Chen C.-L.; Yang W.-T.; Yang H.-C.; TUNG-HUNG SU; Wang C.-C.; Kuo S.F.-T.; Liu C.-H.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:37Z	Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy	Liang C.-C.; Liu C.-H.; Chung C.-S.; Lin C.-K.; TUNG-HUNG SU; Yang H.-C.; Liu C.-J.; Chen P.-J.; Chen D.-S.; Kao J.-H.
臺大學術典藏	2021-03-09T01:47:36Z	Peginterferon plus weight-based ribavirin for treatment-naïve hepatitis C virus genotype 2 patients not achieving rapid virologic response: A randomized trial	Liu C.-H.; Huang C.-F.; Liu C.-J.; Dai C.-Y.; Huang J.-F.; Lin J.-W.; Liang C.-C.; Yang S.-S.; Lin C.-L.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Kao J.-H.; Yu M.-L.
臺大學術典藏	2021-03-09T01:47:35Z	Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: A randomised trial	Liu C.-H.; Liu C.-J.; Huang C.-F.; Lin J.-W.; Dai C.-Y.; Liang C.-C.; Huang J.-F.; Hung P.-H.; Tsai H.-B.; Tsai M.-K.; Lee C.-Y.; Chen S.-I.; Yang S.-S.; TUNG-HUNG SU; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chuang W.-L.; Yu M.-L.; Kao J.-H.

顯示項目 681-730 / 1570 (共32頁)
<< < 9 10 11 12 13 14 15 16 17 18 > >>
每頁顯示[10|25|50]項目

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 51896551 線上人數 : 978 教育部委託研究計畫計畫執行:國立臺灣大學圖書館